"Commentary concerning the publication by Zheng X et al.: Metabolic activation of deferiprone mediated by CYP2A6 (Xenobiotica, published online 18 May 2021)." Xenobiotica, 52(3), pp. 332–333
Disclosure statement
The author is an employee of Chiesi Canada Corp.
Additional information
Funding
Medical writing support was provided by Sarah Mikelman, PhD, of Oxford PharmaGenesis Inc., and was funded by Chiesi USA Inc..